AGP Picks
View all

Healthcare Focus Minnesota
Provided by AGP

Healthcare Focus Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Minnesota.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on November 9, 2026

Curia Memperluas Kapasiti Penapaian di León, Sepanyol
Nov. 9, 2026

Curia Memperluas Kapasiti Penapaian di León, Sepanyol

Indeterminate GlobeNewswire
Curia Expande Capacidade de Fermentação em León, Espanha
Nov. 9, 2026

Curia Expande Capacidade de Fermentação em León, Espanha

Indeterminate GlobeNewswire
Curia ขยายกำลังการผลิตด้วยการหมักที่เมืองเลออน ประเทศสเปน
Nov. 9, 2026

Curia ขยายกำลังการผลิตด้วยการหมักที่เมืองเลออน ประเทศสเปน

Indeterminate GlobeNewswire
Curia 于西班牙莱昂扩大发酵产能
Nov. 9, 2026

Curia 于西班牙莱昂扩大发酵产能

Indeterminate GlobeNewswire
Curia 擴展在西班牙萊昂的發酵產能
Nov. 9, 2026

Curia 擴展在西班牙萊昂的發酵產能

Indeterminate GlobeNewswire
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces MAR001 Reduces Triglycerides Without Worsening Glycemic Control in Phase 2b TYDAL-TIMI 78 Trial; Results Presented as AHA 2026 Late-Breaker and Published in The New England Journal of…
Nov. 9, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces MAR001 Reduces Triglycerides Without Worsening Glycemic Control in Phase 2b TYDAL-TIMI 78 Trial; Results Presented as AHA 2026 Late-Breaker and Published in The New England Journal of…

Indeterminate GlobeNewswire
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
Nov. 9, 2026

Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology

Indeterminate GlobeNewswire
OneMedNet Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap
Nov. 9, 2026

OneMedNet Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap

Indeterminate GlobeNewswire
NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to Market
Nov. 9, 2026

NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to Market

Indeterminate GlobeNewswire
HealthEx is Among the First Consumer Health Apps to Support MyChart Central’s Community Authorization for Single-Login Access to Epic Records
Nov. 9, 2026

HealthEx is Among the First Consumer Health Apps to Support MyChart Central’s Community Authorization for Single-Login Access to Epic Records

Indeterminate GlobeNewswire
LifeStance Health Group Announces Pricing of Secondary Public Offering
Nov. 9, 2026

LifeStance Health Group Announces Pricing of Secondary Public Offering

Indeterminate GlobeNewswire
NeOnc CEO Adds Another 70,000 Shares as Insider Buying Continues
Nov. 9, 2026

NeOnc CEO Adds Another 70,000 Shares as Insider Buying Continues

Indeterminate GlobeNewswire
Vireo Growth Inc. Completes Acquisition of FLUENT Corp.
Nov. 9, 2026

Vireo Growth Inc. Completes Acquisition of FLUENT Corp.

Indeterminate GlobeNewswire
Biodexa provides R&D Update
Nov. 9, 2026

Biodexa provides R&D Update

Indeterminate GlobeNewswire
SAB BIO to Participate in Upcoming Investor Conferences
Nov. 9, 2026

SAB BIO to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026
Nov. 9, 2026

Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026

Indeterminate GlobeNewswire
Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200
Nov. 9, 2026

Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200

Indeterminate GlobeNewswire
New Data at 2026 American Heart Association Scientific Sessions Highlight Cardiovascular Effects of Sotagliflozin on Thrombus Formation and in Hypertrophic Cardiomyopathy
Nov. 9, 2026

New Data at 2026 American Heart Association Scientific Sessions Highlight Cardiovascular Effects of Sotagliflozin on Thrombus Formation and in Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire
Pliant Therapeutics Announces Presentation of PLN-101095 Preclinical and Clinical Data at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer
Nov. 9, 2026

Pliant Therapeutics Announces Presentation of PLN-101095 Preclinical and Clinical Data at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer

Indeterminate GlobeNewswire
Celcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer
Nov. 9, 2026

Celcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Focus Minnesota

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.